首页> 外文期刊>BMC Pulmonary Medicine >Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study
【24h】

Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study

机译:慢性阻塞性肺疾病加重时的家庭脉搏血氧饱和度测定:前瞻性研究

获取原文
           

摘要

Background The ability to objectively differentiate exacerbations of chronic obstructive pulmonary disease (COPD) from day-to-day symptom variations would be an important development in clinical practice and research. We assessed the ability of domiciliary pulse oximetry to achieve this. Methods 40 patients with moderate-severe COPD collected daily data on changes in symptoms, heart-rate (HR), oxygen saturation (SpO2) and peak-expiratory flow (PEF) over a total of 2705 days. 31 patients had data suitable for baseline analysis, and 13 patients experienced an exacerbation. Data were expressed as multiples of the standard deviation (SD) observed from each patient when stable. Results In stable COPD, the SD for HR, SpO2 and PEF were approximately 5 min-1, 1% and 10l min-1. There were detectable changes in all three variables just prior to exacerbation onset, greatest 2-3 days following symptom onset. A composite Oximetry Score (mean magnitude of SpO2 fall and HR rise) distinguished exacerbation onset from symptom variation (area under receiver-operating characteristic curve, AUC = 0.832, 95%CI 0.735-0.929, p = 0.003). In the presence of symptoms, a change in Score of ≥1 (average of ≥1SD change in both HR and SpO2) was 71% sensitive and 74% specific for exacerbation onset. Conclusion We have defined normal variation of pulse oximetry variables in a small sample of patients with COPD. A composite HR and SpO2 score distinguished exacerbation onset from symptom variation, potentially facilitating prompt therapy and providing validation of such events in clinical trials.
机译:背景技术客观地区分慢性阻塞性肺疾病(COPD)恶化与日常症状变化的能力将是临床实践和研究中的重要发展。我们评估了家中脉搏血氧饱和度测定法的能力。方法40例中重度COPD患者每天收集有关症状,心率(HR),血氧饱和度(SpO 2 )和呼气峰流量(PEF)变化的数据,共计2705天。 31例患者的数据适合进行基线分析,而13例患者病情加重。数据表示为稳定时从每个患者观察到的标准偏差(SD)的倍数。结果在稳定的COPD中,HR,SpO 2 和PEF的SD分别约为5 min -1 ,1%和10l min -1 。加重发作前所有三个变量都有可检测到的变化,症状发作后2-3天最大。复合血氧饱和度评分(SpO 2 下降和HR上升的平均幅度)将发作加重与症状变化(在接受者操作特征曲线下的面积,AUC = 0.832,95%CI 0.735-0.929,p = 0.003)。在出现症状时,得分≥1(HR和SpO 2 均≥1SD变化)的敏感性为71%,特异度为发作的74%。结论我们已经定义了一小部分COPD患者脉搏血氧饱和度变量的正常变化。 HR和SpO 2 复合评分可将症状发作加重与症状变化区分开,可能有助于迅速治疗并在临床试验中验证此类事件的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号